Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 2
2010 3
2011 2
2012 2
2013 5
2014 7
2015 7
2016 4
2017 10
2018 10
2019 4
2020 18
2021 17
2022 12
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial.
Pusztai L, Yau C, Wolf DM, Han HS, Du L, Wallace AM, String-Reasor E, Boughey JC, Chien AJ, Elias AD, Beckwith H, Nanda R, Albain KS, Clark AS, Kemmer K, Kalinsky K, Isaacs C, Thomas A, Shatsky R, Helsten TL, Forero-Torres A, Liu MC, Brown-Swigart L, Petricoin EF, Wulfkuhle JD, Asare SM, Wilson A, Singhrao R, Sit L, Hirst GL, Berry S, Sanil A, Asare AL, Matthews JB, Perlmutter J, Melisko M, Rugo HS, Schwab RB, Symmans WF, Yee D, Van't Veer LJ, Hylton NM, DeMichele AM, Berry DA, Esserman LJ. Pusztai L, et al. Among authors: thomas a. Cancer Cell. 2021 Jul 12;39(7):989-998.e5. doi: 10.1016/j.ccell.2021.05.009. Epub 2021 Jun 17. Cancer Cell. 2021. PMID: 34143979 Free article. Clinical Trial.
Late Recurrence Following Early Breast Cancer.
Thomas A, Parsons HA, Smith KL. Thomas A, et al. J Clin Oncol. 2022 May 1;40(13):1400-1406. doi: 10.1200/JCO.22.00167. Epub 2022 Mar 3. J Clin Oncol. 2022. PMID: 35239445 Free PMC article. Review.
Use of non-ionizing electromagnetic fields for the treatment of cancer.
Jimenez H, Blackman C, Lesser G, Debinski W, Chan M, Sharma S, Watabe K, Lo HW, Thomas A, Godwin D, Blackstock W, Mudry A, Posey J, O'Connor R, Brezovich I, Bonin K, Kim-Shapiro D, Barbault A, Pasche B. Jimenez H, et al. Among authors: thomas a. Front Biosci (Landmark Ed). 2018 Jan 1;23(2):284-297. doi: 10.2741/4591. Front Biosci (Landmark Ed). 2018. PMID: 28930547 Free article. Review.
Climate Change and Cancer Care-Feeling the Heat.
Schiller JH, Bernicker E, Thomas A. Schiller JH, et al. Among authors: thomas a. JAMA Oncol. 2023 Nov 1;9(11):1495-1496. doi: 10.1001/jamaoncol.2023.3511. JAMA Oncol. 2023. PMID: 37768656
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.
Page DB, Bear H, Prabhakaran S, Gatti-Mays ME, Thomas A, Cobain E, McArthur H, Balko JM, Gameiro SR, Nanda R, Gulley JL, Kalinsky K, White J, Litton J, Chmura SJ, Polley MY, Vincent B, Cescon DW, Disis ML, Sparano JA, Mittendorf EA, Adams S. Page DB, et al. Among authors: thomas a. NPJ Breast Cancer. 2019 Oct 8;5:34. doi: 10.1038/s41523-019-0130-x. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 31602395 Free PMC article. Review.
101 results